Balan, Mirela
Trusohamn, Marta
Ning, Frank Chenfei
Jacob, Stefan
Pietras, Kristian http://orcid.org/0000-0001-6738-4705
Eriksson, Ulf http://orcid.org/0000-0002-4439-3980
Berggren, Per-Olof
Nyqvist, Daniel http://orcid.org/0000-0002-6527-6716
Funding for this research was provided by:
Vetenskapsrådet
Familjen Erling-Perssons Stiftelse
Novo Nordisk Fonden
Stichting af Jochnick Foundation
Diabetesförbundet
Berth von Kantzows Stiftelse
Karolinska Institutet
Scandia Insurance Company Ltd
Cancerfonden
Svenska Sällskapet för Medicinsk Forskning
Stiftelsen Sigurd and Elsa Goljes Minne
O. E. och Edla Johanssons Vetenskapliga Stiftelse
Magnus Bergvalls Stiftelse
Jeanssons Stiftelser
Article History
Received: 30 May 2019
Accepted: 24 September 2019
First Online: 10 October 2019
Competing Interests
: U.E. is a consultant to CSL Ltd. and is inventor on several patents describing the role of VEGF-B in diabetes and diabetes complications. P-OB is co-founder and CEO of Biocrine, an unlisted biotech company that is using the ACE technique as a research tool.